Pharma Co. Shionogi Sues InterMune Over Drug Royalties

Law360, New York (July 10, 2012, 1:45 PM EDT) -- Japanese pharmaceutical company Shionogi & Co. Ltd. sued InterMune Inc. in California federal court on Thursday for allegedly bilking it out of royalties from sales of a lung disease treatment on which they partnered to win regulatory approval.

The controversy centers on a pact calling for the firms to share documents related to clinical trials each was conducting on the use of pirfenidone in idiopathic pulmonary fibrosis, a potentially fatal disorder involving scarred lung tissue.

California-based InterMune used Shionogi’s data to win European Medicines Agency approval...
To view the full article, register now.




Case Information

Case Title

Shionogi & Co., Ltd. v. InterMune, Inc.

Case Number



California Northern

Nature of Suit

Contract: Other


Elizabeth D. Laporte

Date Filed

July 5, 2012

Law Firms


Government Agencies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.